TCM
IMMU

Taal Capital Management’s Immunomedics Inc IMMU Stock Holding History

Taal Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50,000
Closed -$4.25M – 20
2020
Q3 		$4.25M Buy
+50,000
New +$2.53M 4.17% 13

Taal Capital Management's IMMU Position: Q4 2020 in Review

Taal Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,000 shares — an estimated $4.25M sold.

Taal Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $4.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Taal Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Taal Capital Management sold 50,000 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
  • Taal Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Taal Capital Management's Immunomedics Inc position peaked at $4.25M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Taal Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.